sunitinib krka 12,5 mg cietās kapsulas
krka, d.d., novo mesto, slovenia - sunitinibs - kapsula, cietā - 12,5 mg
weldinin 200 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - sorafenibs - apvalkotā tablete - 200 mg
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiski līdzekļi - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
pazopanib zentiva 200 mg apvalkotās tabletes
zentiva, k.s., czech republic - pazopanibs - apvalkotā tablete - 200 mg
sunitinib viasana 12,5 mg cietās kapsulas
uab viasana, lithuania - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib viasana 25 mg cietās kapsulas
uab viasana, lithuania - sunitinibs - kapsula, cietā - 25 mg
sunitinib viasana 50 mg cietās kapsulas
uab viasana, lithuania - sunitinibs - kapsula, cietā - 50 mg
pazopanib zentiva 400 mg apvalkotās tabletes
zentiva, k.s., czech republic - pazopanibs - apvalkotā tablete - 400 mg
sunitinib stada 12,5 mg cietās kapsulas
stada arzneimittel ag, germany - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib stada 25 mg cietās kapsulas
stada arzneimittel ag, germany - sunitinibs - kapsula, cietā - 25 mg